Vubotics, Inc.
VBTC
$0.00
$0.000.00%
OTC PK
| 09/30/2007 | 06/30/2007 | ||||
|---|---|---|---|---|---|
| Revenue | -37.50% | -96.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -37.50% | -96.67% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -37.50% | -96.67% | |||
| SG&A Expenses | 53.52% | 41.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 39.42% | -12.50% | |||
| Operating Income | -39.57% | 8.43% | |||
| Income Before Tax | -37.71% | 7.11% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -37.71% | 7.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -37.71% | 7.11% | |||
| EBIT | -39.57% | 8.43% | |||
| EBITDA | -39.70% | 8.46% | |||
| EPS Basic | -37.08% | 10.10% | |||
| Normalized Basic EPS | -38.18% | 11.29% | |||
| EPS Diluted | -37.08% | 10.10% | |||
| Normalized Diluted EPS | -38.18% | 11.29% | |||
| Average Basic Shares Outstanding | 0.07% | 3.80% | |||
| Average Diluted Shares Outstanding | 0.07% | 3.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||